| scholarly article | Q13442814 |
| P50 | author | Harry R. Gosker | Q48974961 |
| P2093 | author name string | K A Ward | |
| A M W J Schols | |||
| H Duimel | |||
| M K C Hesselink | |||
| P433 | issue | 1 | |
| P921 | main subject | mitochondrion | Q39572 |
| patient | Q181600 | ||
| P304 | page(s) | 73-79 | |
| P577 | publication date | 2007-04-11 | |
| P1433 | published in | European Respiratory Journal | Q12257435 |
| P1476 | title | Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD | |
| P478 | volume | 30 |
| Q92661462 | An Updated Overview of Metabolomic Profile Changes in Chronic Obstructive Pulmonary Disease |
| Q33901722 | An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease |
| Q54397050 | Autophagy in locomotor muscles of patients with chronic obstructive pulmonary disease. |
| Q35228335 | Bufei Jianpi granules improve skeletal muscle and mitochondrial dysfunction in rats with chronic obstructive pulmonary disease |
| Q58778491 | COPD is accompanied by co-ordinated transcriptional perturbation in the quadriceps affecting the mitochondria and extracellular matrix |
| Q37264397 | Carbon monoxide, skeletal muscle oxidative stress, and mitochondrial biogenesis in humans |
| Q34606406 | Comparative assessment of the quadriceps and the diaphragm in patients with COPD. |
| Q37957593 | Developing the model of pulmonary rehabilitation for chronic heart failure |
| Q37677934 | Eccentric Ergometer Training Promotes Locomotor Muscle Strength but Not Mitochondrial Adaptation in Patients with Severe Chronic Obstructive Pulmonary Disease |
| Q88051558 | Effects of exercise in a cold environment on transcriptional control of PGC-1α |
| Q42085531 | Effects of nutraceutical diet integration, with coenzyme Q10 (Q-Ter multicomposite) and creatine, on dyspnea, exercise tolerance, and quality of life in COPD patients with chronic respiratory failure |
| Q36543123 | Exposure of rats to environmental tobacco smoke during cerebellar development alters behavior and perturbs mitochondrial energetics |
| Q35099434 | Factors associated with impairment of quadriceps muscle function in Chinese patients with chronic obstructive pulmonary disease |
| Q38110749 | Factors limiting exercise tolerance in chronic lung diseases |
| Q35928155 | Failed upregulation of TFAM protein and mitochondrial DNA in oxidatively deficient fibers of chronic obstructive pulmonary disease locomotor muscle |
| Q35154458 | Gait mechanics in patients with chronic obstructive pulmonary disease |
| Q46568235 | Habitual physical activity in daily life correlates positively with markers for mitochondrial capacity |
| Q46210278 | Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (Copd); implications for stratified medicine? |
| Q35086770 | High-energy phosphate transfer in human muscle: diffusion of phosphocreatine |
| Q36850775 | Impaired exercise capacity and skeletal muscle function in a mouse model of pulmonary inflammation |
| Q41673379 | In Vivo Assessment of Mitochondrial Dysfunction in Clinical Populations Using Near-Infrared Spectroscopy |
| Q35053586 | Intramyocellular lipid droplets increase with progression of cachexia in cancer patients |
| Q37945453 | Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning? |
| Q58764012 | Iron deficiency as energetic insult to skeletal muscle in chronic diseases |
| Q35783477 | Leukocyte Mitochondrial DNA Copy Number Is Associated with Chronic Obstructive Pulmonary Disease |
| Q93013804 | Locomotor Muscles in COPD: The Rationale for Rehabilitative Exercise Training |
| Q38071563 | Metabolic derangements in COPD muscle dysfunction. |
| Q39361908 | Mitochondria in chronic obstructive pulmonary disease and lung cancer: where are we now? |
| Q51033534 | Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice. |
| Q26851293 | Mitochondrial dysfunction in heart failure |
| Q57292348 | Molecular signalling towards mitochondrial breakdown is enhanced in skeletal muscle of patients with chronic obstructive pulmonary disease (COPD) |
| Q26775701 | Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings |
| Q34598672 | Muscle oxidative capacity during IL-6-dependent cancer cachexia. |
| Q43241263 | Muscle-fiber transdifferentiation in an experimental model of respiratory chain myopathy |
| Q27304506 | New findings in a global approach to dissect the whole phenotype of PLA2G6 gene mutations |
| Q38091961 | Pathophysiology of muscle dysfunction in COPD. |
| Q38749651 | Patients with Chronic Obstructive Pulmonary Disease Walk with Altered Step Time and Step Width Variability as Compared with Healthy Control Subjects |
| Q37900865 | Peripheral muscle dysfunction in COPD: lower limbs versus upper limbs. |
| Q36093681 | Preferential type II muscle fiber damage from plyometric exercise. |
| Q37407514 | Pulmonary rehabilitation and COPD: providing patients a good environment for optimizing therapy |
| Q63352656 | Quadriceps miR-542-3p and 5p are elevated in COPD and reduce function by inhibiting ribosomal and protein synthesis |
| Q47833542 | Relationship between PPARα mRNA expression and mitochondrial respiratory function and ultrastructure of the skeletal muscle of patients with COPD. |
| Q34903298 | Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function |
| Q38081828 | Should all patients with COPD be exercise trained? |
| Q37115925 | Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease |
| Q36045758 | Skeletal muscle mitochondrial density, gene expression, and enzyme activities in human heart failure: minimal effects of the disease and resistance training |
| Q38078795 | Skeletal muscle mitochondrial dysfunction during chronic obstructive pulmonary disease: central actor and therapeutic target |
| Q37644954 | Structural alterations of skeletal muscle in copd. |
| Q34061404 | Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients |
| Q41434392 | The Effect of a Short Duration, High Intensity Exercise Intervention on Gait Biomechanics in Patients With COPD: Findings From a Pilot Study |
| Q36028206 | The effect of exercise on IL-6-induced cachexia in the Apc ( Min/+) mouse |
| Q34639381 | The effect of neoadjuvant chemoradiotherapy on whole-body physical fitness and skeletal muscle mitochondrial oxidative phosphorylation in vivo in locally advanced rectal cancer patients--an observational pilot study |
| Q38708011 | The influence of iron deficiency on the functioning of skeletal muscles: experimental evidence and clinical implications |
| Q26828616 | The mechanisms of cachexia underlying muscle dysfunction in COPD |
| Q42440941 | The mitochondrial phenotype of peripheral muscle in chronic obstructive pulmonary disease: disuse or dysfunction? |
| Q37129292 | Update in chronic obstructive pulmonary disease 2007. |
| Q51525801 | Ventilatory responses to muscle metaboreflex activation in chronic obstructive pulmonary disease. |
| Q38553569 | Why and How Limb Muscle Mass and Function Should Be Measured in Patients with Chronic Obstructive Pulmonary Disease. |
Search more.